|
||
J. Exp. Med.,
Volume 189, Number 7, April 5, 1999 1121-1128
-Galactosylceramide
Demonstrates Its Immunopotentiating Effect by Inducing
Interleukin (IL)-12 Production by Dendritic Cells and
IL-12 Receptor Expression on NKT Cells
By





From the * Section of Genetic Engineering, Research Center for Genetic Engineering and Cell
Transplantation, and The natural killer T (NKT) cell ligand
Department of Immunology, Tokai University School of Medicine, Isehara
259-1193, Japan; the § Division of Biological Sciences, Graduate School of Science, Hokkaido University,
Sapporo 060-0810, Japan; the
Department of Immunology, Juntendo University School of Medicine,
Tokyo 113-0033, Japan; the ¶ Howard Hughes Medical Institute, Department of Microbiology and
Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and ** Core
Research for Evolutional Science and Technology (CREST) Project and Department of Molecular
Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
-galactosylceramide (
-GalCer) exhibits profound antitumor activities in vivo that resemble interleukin (IL)-12-mediated antitumor activities. Because of these similarities between the activities of
-GalCer and IL-12, we investigated the involvement of IL-12 in the activation of NKT cells by
-GalCer. We first established, using
purified subsets of various lymphocyte populations, that
-GalCer selectively activates NKT
cells for production of interferon (IFN)-
. Production of IFN-
by NKT cells in response to
-GalCer required IL-12 produced by dendritic cells (DCs) and direct contact between NKT
cells and DCs through CD40/CD40 ligand interactions. Moreover,
-GalCer strongly induced the expression of IL-12 receptor on NKT cells from wild-type but not CD1
/
or
V
14
/
mice. This effect of
-GalCer required the production of IFN-
by NKT cells and
production of IL-12 by DCs. Finally, we showed that treatment of mice with suboptimal doses
of
-GalCer together with suboptimal doses of IL-12 resulted in strongly enhanced natural killing activity and IFN-
production. Collectively, these findings indicate an important role
for DC-produced IL-12 in the activation of NKT cells by
-GalCer and suggest that NKT
cells may be able to condition DCs for subsequent immune responses. Our results also suggest
a novel approach for immunotherapy of cancer.
-galactosylceramide;
interleukin 12;
interleukin 12 receptor
This article has been cited by other articles:
| TABLE OF CONTENTS |
|